Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ephedra

This article was originally published in The Tan Sheet

Executive Summary

Several Blue Cross/Blue Shield Web sites now carrying a two-part report on ephedrine alkaloid-containing dietary supplements. The series, developed by Consumer Health Interactive, discusses side effects and adverse events allegedly related to the supplements, as well as FDA regulatory authority. Scientific issues on ephedrine alkaloid-containing supplements are the focus of a Public Health Service meeting Aug. 8-9 in Washington, D.C. (1"The Tan Sheet" July 10, p. 14)

Several Blue Cross/Blue Shield Web sites now carrying a two-part report on ephedrine alkaloid-containing dietary supplements. The series, developed by Consumer Health Interactive, discusses side effects and adverse events allegedly related to the supplements, as well as FDA regulatory authority. Scientific issues on ephedrine alkaloid-containing supplements are the focus of a Public Health Service meeting Aug. 8-9 in Washington, D.C. (1 (Also see "Ephedrine Supplement Risks, Outcome Variables Subject Of USPHS Meeting" - Pink Sheet, 10 Jul, 2000.)).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091457

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel